Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 18;20(2):403.
doi: 10.3390/ijms20020403.

Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease

Affiliations
Review

Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease

Paloma González-Sánchez et al. Int J Mol Sci. .

Abstract

The pathology of Charcot-Marie-Tooth (CMT), a disease arising from mutations in different genes, has been associated with an impairment of mitochondrial dynamics and axonal biology of mitochondria. Mutations in ganglioside-induced differentiation-associated protein 1 (GDAP1) cause several forms of CMT neuropathy, but the pathogenic mechanisms involved remain unclear. GDAP1 is an outer mitochondrial membrane protein highly expressed in neurons. It has been proposed to play a role in different aspects of mitochondrial physiology, including mitochondrial dynamics, oxidative stress processes, and mitochondrial transport along the axons. Disruption of the mitochondrial network in a neuroblastoma model of GDAP1-related CMT has been shown to decrease Ca2+ entry through the store-operated calcium entry (SOCE), which caused a failure in stimulation of mitochondrial respiration. In this review, we summarize the different functions proposed for GDAP1 and focus on the consequences for Ca2+ homeostasis and mitochondrial energy production linked to CMT disease caused by different GDAP1 mutations.

Keywords: GDAP1; calcium regulated cell respiration; mitochondrial location; recessive mutations; store operated calcium entry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effects of ganglioside-induced differentiation-associated protein 1 (GDAP1) on mitochondrial bioenergetic functions. (A) Interaction between GDAP1 and the trafficking proteins allows mitochondria to be located close to the plasma membrane after store-operated calcium entry (SOCE) activation, preventing its Ca2+-dependent inactivation. Ca2+ uptake by mitochondria facilitates SOCE but also regulates ATP production by oxidative phosphorylation. Ca2+-dependent regulation of OXPHOS involves two main mechanisms (dotted red arrows); (i) Ca2+ entry through the mitochondrial Ca2+ uniporter complex (MCUc) and the activation of dehydrogenases of the tricarboxylic acid cycle (TCA), and (ii) activation of the neuronal Ca2+-dependent mitochondrial transporters of aspartate/glutamate (Aralar) or ATP-Mg/Pi (SCaMC-3). Aralar activation increases Malate/Aspartate shuttle (MAS) activity, transferring reducing equivalents from NADH to mitochondria and thereby increasing pyruvate (Pyr) supply to mitochondria to enhance mitochondrial respiration. SCaMC-3 activation increases mitochondrial adenine nucleotide pool (solid and dotted black arrows); (B) Mitochondrial movement might be affected by recessive mutations located in the α-loop of GDAP1 causing the loss of interaction with trafficking proteins RAB6B and caytaxin which might affect the proper mitochondrial localization at the subplasmalemmal microdomains and disturb SOCE activity (red T bar). Subsequently, this will also impair mitochondrial bioenergetic functions by either decreasing Ca2+ uptake by MCUc and activation of matrix dehydrogenases, and/or by decreasing the activation of Ca2+-dependent mitochondrial transporters.

Similar articles

Cited by

References

    1. Pareyson D., Saveri P., Pisciotta C. New developments in Charcot-Marie-Tooth neuropathy and related diseases. Curr. Opin. Neurol. 2017;30:471–480. doi: 10.1097/WCO.0000000000000474. - DOI - PubMed
    1. Juarez P., Palau F. Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy. Neural Plast. 2012;2012:171636. doi: 10.1155/2012/171636. - DOI - PMC - PubMed
    1. Rossor A.M., Polke J.M., Houlden H., Reilly M.M. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 2013;9:562–571. doi: 10.1038/nrneurol.2013.179. - DOI - PubMed
    1. Rzepnikowska W., Kochanski A. A role for the GDAP1 gene in the molecular pathogenesis of Charcot Marie Tooth disease. Acta Neurobiol. Exp. 2018;78:1–13. doi: 10.21307/ane-2018-002. - DOI - PubMed
    1. Baxter R.V., Ben Othmane K., Rochelle J.M., Stajich J.E., Hulette C., Dew-Knight S., Hentati F., Ben Hamida M., Bel S., Stenger J.E., et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 2002;30:21–22. doi: 10.1038/ng796. - DOI - PubMed